MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/cvr/cvac060

Медицинская библиотека · Cardiovascular research · 2023

Eosinophils protect pressure overload- and β-adrenoreceptor agonist-induced cardiac hypertrophy.

Yang Chongzhe, Li Jie, Deng Zhiyong, Luo Songyuan, Liu Jing, Fang Wenqian, Liu Feng, Liu Tianxiao, Zhang Xian, Zhang Yuanyuan, Meng Zhaojie, Zhang Shuya, Luo Jianfang, Liu Conglin, Yang Dafeng, Liu Lijun, Sukhova Galina K, Sadybekov Anastasiia, Katritch Vsevolod, Libby Peter, Wang Jing, Guo Junli, Shi Guo-Ping

СтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

AIMS: Blood eosinophil (EOS) counts and EOS cationic protein (ECP) levels associate positively with major cardiovascular disease (CVD) risk factors and prevalence. This study investigates the role of EOS in cardiac hypertrophy.

METHODS AND

RESULTS

A retrospective cross-section study of 644 consecutive inpatients with hypertension examined the association between blood EOS counts and cardiac hypertrophy. Pressure overload- and β-adrenoreceptor agonist isoproterenol-induced cardiac hypertrophy was produced in EOS-deficient ΔdblGATA mice. This study revealed positive correlations between blood EOS counts and left ventricular (LV) mass and mass index in humans. ΔdblGATA mice showed exacerbated cardiac hypertrophy and dysfunction, with increased LV wall thickness, reduced LV internal diameter, and increased myocardial cell size, death, and fibrosis. Repopulation of EOS from wild-type (WT) mice, but not those from IL4-deficient mice ameliorated cardiac hypertrophy and cardiac dysfunctions. In ΔdblGATA and WT mice, administration of ECP mEar1 improved cardiac hypertrophy and function. Mechanistic studies demonstrated that EOS expression of IL4, IL13, and mEar1 was essential to control mouse cardiomyocyte hypertrophy and death and cardiac fibroblast TGF-β signalling and fibrotic protein synthesis. The use of human cardiac cells yielded the same results. Human ECP, EOS-derived neurotoxin, human EOS, or murine recombinant mEar1 reduced human cardiomyocyte death and hypertrophy and human cardiac fibroblast TGF-β signalling.

CONCLUSION

Although blood EOS counts correlated positively with LV mass or LV mass index in humans, this study established a cardioprotective role for EOS IL4 and cationic proteins in cardiac hypertrophy and tested a therapeutic possibility of ECPs in this human CVD.

Для цитирования: Yang Chongzhe, Li Jie, Deng Zhiyong, Luo Songyuan, Liu Jing, Fang Wenqian, Liu Feng, Liu Tianxiao, Zhang Xian, Zhang Yuanyuan, Meng Zhaojie, Zhang Shuya, Luo Jianfang, Liu Conglin, Yang Dafeng, Liu Lijun, Sukhova Galina K, Sadybekov Anastasiia, Katritch Vsevolod, Libby Peter, Wang Jing, Guo Junli, Shi Guo-Ping. Eosinophils protect pressure overload- and β-adrenoreceptor agonist-induced cardiac hypertrophy.. Cardiovascular research. 2023. DOI: 10.1093/cvr/cvac060.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.